Woojin B&G’s ‘immunis® Mega Bag’ Vaccine Combats Iridovirus in High-Value Fish, Expanding Globally
Table of Contents
Woojin B&G, a South Korean veterinary pharmaceutical company, is making significant strides in aquaculture health with its ‘Immunis® Mega Bag’ vaccine. This innovative vaccine prevents iridovirus infection, a devastating disease impacting valuable farmed fish species like parrotfish, sea bass, and red sea bream. The vaccine has demonstrated a high success rate in field applications, particularly in parrotfish farming, and is rapidly gaining market share both domestically and internationally. Recent recognition from the Ministry of Oceans and Fisheries underscores the vaccine’s impact and positions Woojin B&G as a leader in aquatic veterinary medicine.
The threat of Iridovirus in Aquaculture
Iridovirus is a highly contagious disease that poses a serious threat to marine fish aquaculture. It causes significant mortality rates, leading to ample economic losses for fish farmers. https://www.sciencefocus.com/nature-environment/what-is-fish-virus Parrotfish, sea bass, and red sea bream are particularly susceptible, making the development of effective preventative measures crucial.These species are considered high-value, adding to the economic importance of protecting them from disease.
‘Immunis® Mega Bag’: A Breakthrough in Prevention
Woojin B&G’s ‘Immunis® Mega Bag’ vaccine offers a solution to this challenge. The vaccine has shown a survival rate exceeding 80% in parrotfish farms previously plagued by frequent mass mortality events. This success is attributed to the vaccine’s ability to stimulate the fish’s immune system, providing protection against iridovirus infection.
the development and commercialization of the vaccine were supported by a research project (‘Site-kind process research and entry into the global market for the world’s first parrot iridovirus prevention vaccine’) funded by the Ministry of Oceans and Fisheries’ Korea Institute for Oceans and Fisheries Science and Technology Promotion. This collaboration has been instrumental in refining the vaccine and preparing it for wider distribution.
Rapid Domestic Growth and Global Expansion
Since its initial launch in 2022, ‘Immunis® Mega Bag’ has experienced rapid growth, particularly in the key aquaculture regions of Tongyeong and Geoje in South Gyeongsang Province. The company reports an average annual growth rate of 97% https://www.koreatimes.co.kr/www/tech/2024/12/13/140869.html, demonstrating strong demand from fish farmers. Recent expansion of the supply chain to Yeosu, Jeollanam-do, further solidifies its position as a leading fish vaccine in the Korean market.
Woojin B&G is also actively pursuing international opportunities. Export discussions are underway with potential partners in major Asian aquaculture countries, including Indonesia, Japan, Taiwan, Vietnam, and Thailand.This expansion reflects the global need for effective iridovirus prevention strategies.
Ministerial Citation and Future Outlook
Woojin B&G’s success was recently recognized with a Ministerial Citation, acknowledging the international competitiveness of its K-Susan vaccine technology. An official from the Woojin B&G Vaccine Research Institute stated that this award validates their technological advancements and commitment to innovation. https://www.koreatimes.co.kr/www/tech/2024/12/13/140869.html
Looking ahead, Woojin B&G plans to accelerate its efforts to expand into the global market and establish itself as a leading veterinary pharmaceutical company in Korea. The company’s success with the parrotfish iridovirus vaccine serves as a foundation for developing and commercializing vaccines for other aquatic diseases, contributing to the sustainability and economic viability of aquaculture worldwide.
Key Takeaways:
* Effective Prevention: ‘Immunis® Mega Bag’ demonstrates over 80% survival rates in parrotfish farms affected by iridovirus.
* Rapid Growth: The vaccine has experienced a 97% average annual growth rate in South Korea.
* Global Potential: Export discussions are underway with key aquaculture countries in Asia.
* Industry Recognition: Woojin B&G received a Ministerial Citation for its innovative vaccine technology.